Pharmacy Compounding Advisory Committee

The Committee discussed five bulk drug substances nominated for inclusion on the section 503A Bulks List.

  1. Diindolylmethane - Treatment of cancer
  2. Glycolic acid - Hyperpigmentation (including melasma) and photodamaged skin
  3. Trichloroacetic acid - Common warts and genital warts
  4. Kojic acid - Hyperpigmentation and as a chelating agent to promote wound healing
  5. Vasoactive intestinal peptide - A condition described as “chronic inflammatory response syndrome”

The Committee also discussed drug products that employ transdermal and topical delivery systems, which were nominated for the Difficult to Compound List.